Recipient(s) will receive an email with a link to 'Fructosamine, Serum' and will have access to the topic for 7 days.
Subject: Fructosamine, Serum
(Optional message may have a maximum of 1000 characters.)
Fructosamine describes serum proteins that have been glycated (i.e., derivatives of nonenzymatic reaction product of a sugar [glucose] with serum protein [albumin]). It reflects the mean glucose concentration in blood over recent period (2–3 weeks), whereas glycated Hb (HbA1c) is indicative of blood glucose over intermediate to long term (4–8 weeks).
Normal range (nondiabetic individuals): 170–285 μmol/L.
To assess short-term glycemic control in diabetic patients.
When glycated Hb cannot be used due to interferences (e.g., abnormal Hb), which invalidate HbA1c.
It should be compared with previous values in the same patient rather than reference range.
Hyperglycemia in patients with poorly controlled DM
Because the assay is nonspecific, color may be generated by compounds other than glycated proteins. Interferences are seen from ascorbic acid (vitamin C) and elevated bilirubin values. However, the second-generation assays have been shown to be highly specific for glycated proteins.
Fasting blood glucose and HbA1c are the usual and preferred means of monitoring glycemic control.
Changes in fructosamine values correlate with significant changes in serum protein concentrations (e.g., liver disease, acute systemic illness). Abnormal values also occur during abnormal protein turnover (e.g., thyroid disease), even though patients are normoglycemic. It may be obviated by using fructose: albumin ratio.
The within-subject variation for serum fructosamine is higher than that for HbA1C; as a result, serum fructosamine concentrations must change more before a significant change can be said to have occurred.